Resmed Inc. buy Royal Bank of Canada
Start price
31.10.25
/
50%
€212.60
Target price
31.10.26
€261.85
Performance (%)
-1.55%
Price
05.01.26
€209.30
Summary
This prediction is currently active. With a performance of -1.55%, the BUY prediction for Resmed Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 31.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 1.454% | 1.454% |
| iShares Core DAX® | 2.032% | 3.499% |
| iShares Nasdaq 100 | -0.145% | -1.849% |
| iShares Nikkei 225® | 4.507% | 1.976% |
| iShares S&P 500 | 0.331% | -0.103% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its price target raised by analysts at Royal Bank Of Canada from $300.00 to $303.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat